Market revenue in 2021 | USD 3.2 million |
Market revenue in 2030 | USD 5.6 million |
Growth rate | 6.4% (CAGR from 2021 to 2030) |
Largest segment | Quadrivalent |
Fastest growing segment | Quadrivalent |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bivalent, Quadrivalent |
Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 71.88% in 2021. Horizon Databook has segmented the Chile meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing incidence of meningococcal disease, high awareness level, and better immunization programs in Chile are some of major factors driving market growth. The incidence rate of IMD is estimated around 0.44 cases per 100,000 population in the country, whereas there was a 90% downfall in IMD cases in 2020 compared to 2019.
Inclusion of meningococcal vaccine in immunization program has significantly boosted market growth. The outbreak of Men W in 2012 has increased meningococcal vaccine campaign in the country, due to inclusion of quadrivalent Men ACWY conjugate vaccine into the National Immunization Program for infants and children.
Increase in vaccination rate against meningococcal diseases has significantly reduced the incidence rate. Moreover, increase research activities related to immunogenicity and tolerability of meningococcal vaccine is expected to drive the vaccine demand in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Chile meningococcal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Chile meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account